Skip to main
AVAH
AVAH logo

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 38%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Holdings Inc. reported a revenue rate of $495.43, representing a 0.6% increase, with a gross margin improvement to 32.6%, surpassing expectations, and benefiting from strong performance in Private Duty Services (PDS). The Home Health & Hospice (HHH) segment experienced robust growth, with revenue reaching $62.4 million, up 15.3% year-over-year, driven by a notable increase in both total and episodic admissions. Furthermore, the company has raised its guidance, now forecasting revenue of over $2.375 billion, indicating a positive outlook on its financial health and growth trajectory.

Bears say

Aveanna Healthcare Holdings Inc. faces significant downside risks that contribute to a negative outlook on its stock, including potential reimbursement pressures and high leverage. Additionally, labor headwinds are expected to negatively impact adjusted EBITDA estimates by approximately 10% in fiscal year 2026, while gross margins have shown a decline year-over-year. The company's anticipated challenges with organic growth, regulatory issues, and increased competition further exacerbate concerns over its financial stability and operational effectiveness.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 38% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.19, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.19, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.